The DOI matches its Crossref record.
A C-Terminal Fragment of Agouti-Related Protein Increases Feeding and Antagonizes the Effect of Alpha-Melanocyte Stimulating Hormone in Vivo
Abstract
Agouti-related protein (Agrp) is present in rat and human hypothalamus and is structurally related to agouti protein. Overexpression of either of these proteins results in obesity. However the effect of exogenous Agrp and its in vivo interaction with alpha-melanocyte stimulating hormone (alphaMSH), the likely endogenous melanocortin 3 and 4 receptor (MC3-R and MC4-R) agonist, have not been demonstrated. We report that 1 nmol of Agrp(83-132), a C-terminal fragment of Agrp, when administered intracerebroventricularly (ICV) into rats, increased food intake over a 24-h period (23.0+/-1.4 g saline vs 32.9+/-2.3 g Agrp, p<0.05). The hyperphagia was similar to that seen when 1 nmol of the synthetic MC3-R and MC4-R antagonist SHU9119 was given i.c.v. (19.6+/-1.8 g saline vs 32.5+/-1.7 g SHU9119, p<0.001). Both Agrp(83-132) and SHU9119 blocked the reduction in 1-h food intake of i.c.v. alphaMSH at the beginning of the dark phase. This effect occurred independently of whether the antagonists were administered simultaneously, or nine hours prior, to the alphaMSH. We have also shown Agrp(83-132) is an antagonist at the MC3-R and MC4-R, with similar inhibition of cAMP activation to that previously reported for the full length peptide. In conclusion, Agrp(83-132) administered i.c.v. increases feeding with long lasting effects and is able to inhibit the action of alphaMSH. This interaction may be mediated by the MC3-R and/or MC4-R.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast to its pro-opiomelanocortin-stimulating action, insulin inhibits NPY expression144 in Agouti-related peptide (AgRP/NPY) neurons, which are known to secrete the orexigenic neuropeptides NPY145, 146, 147 and AgRP.148, 149”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [149]
Citations
Cited by
Sorted by citations
Items 101–200 of 580
Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment
Kim, E. K., Miller, I., Landree, L. E., Borisy-Rudin, F. F., Brown, P., Tihan, T., Townsend, C. A., Witters, L. A., Moran, T. H., Kuhajda, F. P., et al. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00178.2002 · Cited by 129
“NPY (42, 64) and agouti gene-related peptide (AGRP) (29, 48, 54) are orexigenic peptides in medial arcuate neurons that act to increase food intake.”
BackgroundInfluentialInvestigation of the melanocyte stimulating hormones on food intake
Abbott, C. R., Rossi, M., Kim, M.-S., AlAhmed, S. H., Taylor, G. M., Ghatei, M. A., Smith, D. M., & Bloom, S. R. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02386-6 · Cited by 127
Self-citationThe Melanocortin-3 Receptor Is Required for Entrainment to Meal Intake
Sutton, G. M., Pérez–Tilve, D., Nogueiras, R., Fang, J., Kim, J. K., Cone, R. D., Gimble, J. M., Tschöp, M. H., & Butler, A. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3615-08.2008 · Cited by 132
“Melanocyte-stimulating hormones ( -, - and -MSH) are produced by post-translational processing of proopiomelanocortin in neurons residing in the arcuate nucleus of the hypothalamus (ARC) (Cone, 2005, 2006).”
BackgroundAppetite Regulation: An Overview
Dhillo, W. S. (2007) · Thyroid · doi:10.1089/thy.2007.0018 · Cited by 127
“ICV administration of a -MSH decreases food intake and ICV administered AgRP increases food intake (12).”
Abbott, C. R., Kennedy, A. R., Wren, A., Rossi, M., Murphy, K. G., Seal, L., Todd, J. F., Ghatei, M. A., Small, C. J., & Bloom, S. R. (2003) · Endocrinology · doi:10.1210/en.2003-0149 · Cited by 135
“ICV administration of NPY or AgRP significantly increases food intake (41, 42).”
BackgroundSelf-citationGENETIC MODELS OF OBESITY AND ENERGY BALANCE IN THE MOUSE
Robinson, S. W., Dinulescu, D. M., & Cone, R. D. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.687 · Cited by 122
The Role of PVH Circuits in Leptin Action and Energy Balance
Sutton, A. K., Myers, M. G., & Olson, D. P. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105347 · Cited by 126
Légrádi, G., & Lechan, R. M. (1999) · Endocrinology · doi:10.1210/endo.140.8.6935 · Cited by 127
“AGRP is thought to exert its main effects by binding to melanocortin receptors and antagonizing the actions of POMC-derived peptides such as a-MSH ( 37 ).”
BackgroundMarsh, D. J., Miura, G. I., Yagaloff, K. A., Schwartz, M. W., Barsh, G. S., & Palmiter, R. D. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01962-9 · Cited by 118
Self-citationRamsey, K. M., Marcheva, B., Kohsaka, A., & Bass, J. T. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093546 · Cited by 120
“While studies of SCN architecture have advanced our understanding of CNS timekeeping , a distinct line of investigation has focused on the localization of neuronal centers CART: cocaineand amphetamine- regulated transcript α-MSH: α-melanocytestimulating hormone NPY: neuropeptide Y AgRP: agouti-related protein involved…”
InfluentialThoughts for Food: Brain Mechanisms and Peripheral Energy Balance
Abizaid, A. B., Gao, Q., & Horváth, T. L. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.025 · Cited by 122
Poor Cell Surface Expression of Human Melanocortin-4 Receptor Mutations Associated with Obesity
Nijenhuis, W. A. J., Garner, K. M., van Rozen, R. J., & Adan, R. A. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211326200 · Cited by 115
Titolo, D., Cai, F., & Belsham, D. D. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0027 · Cited by 115
“AgRP is an endogenous antagonist of MC4R receptor signaling, thereby promoting food intake (9, 10).”
BackgroundWirth, M. M., Olszewski, P. K., Yu, C., Levine, A. S., & Giraudo, S. Q. (2001) · Peptides · doi:10.1016/s0196-9781(00)00367-3 · Cited by 115
Creemers, J. W. M., Pritchard, L. E., Gyte, A., Rouzic, P. L., Meulemans, S. M. P., Wardlaw, S. L., Zhu, X., Steiner, D. F., Davies, N., Armstrong, D., et al. (2005) · Endocrinology · doi:10.1210/en.2005-1373 · Cited by 112
Unraveling the Central Proopiomelanocortin Neural Circuits
Mercer, A. J., Hentges, S. T., Meshul, C. K., & Low, M. J. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00019 · Cited by 118
“While the orexigenic function of AgRP and NPY peptides is well documented (Ollmann et al., 1997; Hollopeter et al., 1998; Rossi et al., 1998), further studies have probed which transmitter released by AgRP/NPY neurons www.frontiersin.org February 2013 | Volume 7 | Article 19 | 3 is critical for the…”
BackgroundAnti-obesity drugs: a critical review of current therapies and future opportunities
Clapham, J. C. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00105-4 · Cited by 111
When do we eat? Ingestive behavior, survival, and reproductive success
Schneider, J. E., Wise, J. D., Benton, N. A., Brozek, J. M., & Keen‐Rhinehart, E. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2013.07.005 · Cited by 109
Seo, S., Ju, S., Chung, H., Lee, D., & Seungjoon, P. A. R. K. (2008) · Endocrine Journal · doi:10.1507/endocrj.k08e-091 · Cited by 109
Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes
Mountjoy, K. G. (2010) · Biochemical Journal · doi:10.1042/bj20091957 · Cited by 110
Cognitive and autonomic determinants of energy homeostasis in obesity
Richard, D. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.103 · Cited by 113
Fahrenkrog, S., Harder, T., Stolaczyk, E., Melchior, K., Franke, K., Dudenhausen, J. W., & Plagemann, A. (2004) · Journal of Nutrition · doi:10.1093/jn/134.3.648 · Cited by 108
“Within the anorexigenic POMC-MSH system, agouti-related peptide (AGRP) acts as a physiological antagonist at the melanocortin-4 (MC-4) receptor, thereby exerting orexigenic effects (14).”
BackgroundThe hyperphagic effect of nociceptin/orphanin FQ in rats.
Polidori, C., CARO, G. D., & Massi, M. (2000) · Peptides · doi:10.1016/s0196-9781(00)00243-6 · Cited by 102
Regulation of substrate utilization and adiposity by Agrp neurons
Cavalcanti‐de‐Albuquerque, J. P., Bober, J., Zimmer, M. R., & Dietrich, M. O. (2019) · Nature Communications · doi:10.1038/s41467-018-08239-x · Cited by 112
Tachibana, T., Sugahara, K., Ohgushi, A., Ando, R., Kawakami, S.-I., Yoshimatsu, T., & Furuse, M. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01827-4 · Cited by 100
Neuroendocrine mechanisms regulating food intake and body weight
McMinn, J. E., Baskin, D. G., & Schwartz, M. W. (2000) · Obesity Reviews · doi:10.1046/j.1467-789x.2000.00007.x · Cited by 97
“Furthermore, injections of NPY, AgRP, MCH, and ORX directly into the brain increase food intake (31,32,34,35), whereas CRH, and POMC derivatives such as a-MSH, have the opposite effect (36,37) (Fig.”
BackgroundDunbar, J. C., & Lu, H. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00197-5 · Cited by 100
Mihály, E., Fekete, C., Tatro, J. B., Liposits, Z., Stopa, E. G., & Lechan, R. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6662 · Cited by 106
“Similarly, in the brain, AGRP competes with aMSH for binding to the MC-4R, inhibiting the anorectic effects of aMSH and inducing feeding behavior (10, 35).”
BackgroundMayer, C., & Belsham, D. D. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.02.031 · Cited by 103
“, 1986) or AgRP (Rossi et al., 1998) increases food intake and body weight and chronic administration results in obesity.”
BackgroundCNS Melanocortin System Involvement in the Regulation of Food Intake
Benoit, S. C., Schwartz, M. W., Baskin, D. G., Woods, S. C., & Seeley, R. J. (2000) · Hormones and Behavior · doi:10.1006/hbeh.2000.1588 · Cited by 100
Watts, A. G. (2000) · Hormones and Behavior · doi:10.1006/hbeh.2000.1581 · Cited by 98
Integrating Hunger with Rival Motivations
Hickey, A. K. S., & Krashes, M. J. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.04.006 · Cited by 96
Chronic CNS administration of Agouti-related protein (Agrp) reduces energy expenditure
Small, C. J., Liu, Y., Stanley, S. A., Connoley, I. P., Kennedy, A., Stock, M. J., & Bloom, S. R. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802253 · Cited by 97
Self-citationThe Role of the Agouti-Related Protein in Energy Balance Regulation
Ilnytska, O., & Argyropoulos, G. A. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8104-4 · Cited by 97
GABAergic Nature of Hypothalamic Leptin Target Neurones in the Ventromedial Arcuate Nucleus
Ovesjö, M., Gamstedt, M., Collin, M., & Meister, B. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00662.x · Cited by 100
Kumar, K. G., Sutton, G. M., Dong, J. Z., Roubert, P., Plas, P., Halem, H. A., Culler, M. D., Yang, H., Dixit, V. D., & Butler, A. A. (2009) · Peptides · doi:10.1016/j.peptides.2009.07.012 · Cited by 98
“Central administration of AgRP promotes weight gain by increasing food intake and reducing energy expenditure [35,39].”
BackgroundChisada, S., Kurokawa, T., Murashita, K., Rønnestad, I., Taniguchi, Y., Toyoda, A., Sakaki, Y., Takeda, S., & Yoshiura, Y. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.10.008 · Cited by 95
Williams, K. W., Scott, M. M., & Elmquist, J. K. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.11.042 · Cited by 96
“One of the melanocortins, α-MSH—an MC3/4 receptor agonist, and its analogs potently inhibits food intake in the brain via activation of central melanocortin neurons (Fan et al., 1997; Ludwig et al., 1998; Rossi et al., 1998; Tsujii and Bray, 1989).”
Ehrlich, S., Weiss, D., Burghardt, R., Infante‐Duarte, C., Brockhaus, S., Muschler, M. A. N., Bleich, S., Lehmkuhl, U., & Frieling, H. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.01.011 · Cited by 97
“In contrast, central administration of agouti-related peptide (AGRP), which is inhibited by leptin and acts as an selective antagonist on MC3R and MC4R, leads to an increase in food uptake for up to one week (Rossi et al., 1998).”
BackgroundDevelopmental programming of hypothalamic neuronal circuits: impact on energy balance control
Ramamoorthy, T. G., Begum, G., Harno, E., & White, A. E. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00126 · Cited by 101
Fraley, G. S., & Ritter, S. (2002) · Endocrinology · doi:10.1210/en.2002-220659 · Cited by 92
“injection of AGRP causes pronounced and prolonged elevation of food intake in rats (13, 14), with the most potent site”
BackgroundMul, J. D., van Boxtel, R., Bergen, D. J. M., Brans, M. A. D., Brakkee, J. H., Toonen, P. W., Garner, K. M., Adan, R. A. H., & Cuppen, E. P. J. G. (2011) · Obesity · doi:10.1038/oby.2011.81 · Cited by 93
“The statistical analysis for body weight growth on a chow diet revealed a significant effect of time (F(4,28) = 111; P < 0.”
BackgroundDaniels, D., Patten, C. S., Roth, J. D., Yee, D. K., & Fluharty, S. J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03162-7 · Cited by 92
Semjonous, N. M., Smith, K. L., Parkinson, J. R. C., Gunner, D. J., Liu, Y., Murphy, K. G., Ghatei, M. A., Bloom, S. R., & Small, C. J. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.96 · Cited by 90
“ACTH-(1-24) and alpha-MSH antagonize feeding behavior stimulated by kappa opiate agonists.”
BackgroundSelf-citationDrougard, A., Fournel, A., Valet, P., & Knauf, C. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00056 · Cited by 93
“These neurons express neuropeptide Y (NPY) and the agouti-gene-related transcript (AgRP) (Clark et al., 1984; Rossi et al., 1998) which stimulate food intake and reduce energy expenditure (Fekete et al., 2002).”
BackgroundHagan, M. M., Benoit, S. C., Rushing, P. A., Pritchard, L. M., Woods, S. C., & Seeley, R. J. (2001) · Endocrinology · doi:10.1210/endo.142.3.8018 · Cited by 91
“Central administration of the fragment AgRP-(83‐ 132) (14) increases food intake ( 15 ).”
BackgroundInfluentialHypothalamic Melanocortin System Regulates Sympathetic Nerve Activity in Brown Adipose Tissue
Yasuda, T., Masaki, T., Kakuma, T., & Yoshimatsu, H. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422900303 · Cited by 89
“The results were consistent with previous studies in which MC4-R agonists Or antagonists suppressed or stimulated food intake, respectively (3, 4, 10-12, 18, 19).”
BackgroundResultHanada, R., Nakazato, M., Matsukura, S., Murakami, N., Yoshimatsu, H., & Sakata, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.2081 · Cited by 88
Diurnal Rhythm of Agouti-Related Protein and Its Relation to Corticosterone and Food Intake
Lu, X., Shieh, K.-R., Kabbaj, M., Barsh, G. S., Akil, H., & Watson, S. J. (2002) · Endocrinology · doi:10.1210/en.2002-220150 · Cited by 87
Bäckberg, M., Collin, M., Ovesjö, M., & Meister, B. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.00843.x · Cited by 85
Phillips-Singh, D., Li, Q., Takeuchi, S., Ohkubo, T., Sharp, P. J., & Boswell, T. (2003) · Cell and Tissue Research · doi:10.1007/s00441-003-0755-8 · Cited by 84
“AGRP acts as an antagonist to the MC-receptors (Ollmann et al. 1997), lifting their tonic inhibition, and thereby stimulating food intake when injected into the brain (Rossi et al. 1998).”
BackgroundFu, L., & van den Pol, A. N. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0749-08.2008 · Cited by 92
“Intracerebroventricular administration of AgRP stimulates feeding (Rossi et al., 1998), and transgenic overexpression of AgRP causes Received March 20, 2007; revised April 8, 2008; accepted April 9, 2008.”
BackgroundScarlett, J. M., Zhu, X., Enriori, P. J., Bowe, D. D., Batra, A. K., Levasseur, P. R., Grant, W. F., Meguid, M. M., Cowley, M. A., & Marks, D. L. (2008) · Endocrinology · doi:10.1210/en.2007-1680 · Cited by 84
“AgRP promotes food intake and positive energy balance via inhibition of -MSH-stimulated signaling, and inverse agonism at the type 3 and 4 central melanocortin receptors (MC4-R) (9, 11, 12 ).”
BackgroundMizuno, T. M., Kelley, K. A., Pasinetti, G. M., Roberts, J. L., & Mobbs, C. V. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2675 · Cited by 85
Central regulation of food intake in the neonatal chick
Furuse, M. (2002) · Animal Science Journal · doi:10.1046/j.1344-3941.2002.00014.x · Cited by 82
Recent developments in our understanding of melanocortin system in the regulation of food intake
Yang, Y., & Harmon, C. M. (2003) · Obesity Reviews · doi:10.1046/j.1467-789x.2003.00104.x · Cited by 80
The importance of estradiol for body weight regulation in women
Pilar Vigil, P., Meléndez, J., Petkovic, G., & Río, J. P. D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.951186 · Cited by 84
“The ARC contains two main types of neuronal systems: appetitesuppressing POMC neurons (75, 76); and, appetite-stimulating NPY/AgRP neurons (75, 77).”
BackgroundVulliémoz, N. R., Xiao, E., Xia‐Zhang, L., Wardlaw, S. L., & Ferin, M. (2004) · Endocrinology · doi:10.1210/en.2004-1093 · Cited by 80
Santollo, J., & Eckel, L. A. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.03.019 · Cited by 80
“MC3/4 receptors, is an endogenous antagonist of the melanocortin system [26,32].”
BackgroundHarrold, J. A., Williams, G., & Widdowson, P. S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0675 · Cited by 80
NPY ablation in C57BL/6 mice leads to mild obesity and to an impaired refeeding response to fasting
Segal‐Lieberman, G., Trombly, D. J., Juthani, V. V., Wang, X., & Maratos–Flier, E. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00491.2002 · Cited by 80
Takeuchi, S., Teshigawara, K., & Takahashi, S. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00022-7 · Cited by 78
Effects of fasting, leptin, and insulin on AGRP and POMC peptide release in the hypothalamus
Breen, T. L., Conwell, I. M., & Wardlaw, S. L. (2004) · Brain Research · doi:10.1016/j.brainres.2004.11.008 · Cited by 78
THE NEUROENDOCRINOLOGY OF CHILDHOOD OBESITY
Lustig, R. H. (2001) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70348-5 · Cited by 78
Sánchez, E., Rubio, V. C., Thompson, D. A., Metz, J. R., Flik, G., Millhauser, G. L., & Cerdá‐Reverter, J. M. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90948.2008 · Cited by 76
Agouti-related protein in the hypothalamic paraventricular nucleus: effect on feeding
Wirth, M. M., & Giraudo, S. Q. (2000) · Peptides · doi:10.1016/s0196-9781(00)00280-1 · Cited by 77
Lawrence, C. B., Liu, Y.-L., Stock, M. J., & Luckman, S. M. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00402.2003 · Cited by 76
“Since higher doses of SHU9119 can initiate food intake at later time points (9, 40), we confirmed also that it did not reverse the effect of PrRP on cumulative food intake over an 8 h period.”
BackgroundGliotransmission and Brain Glucose Sensing
Lanfray, D., Arthaud, S., Ouellet, J., Compère, V., do Rego, J. L., Leprince, J., Lefranc, B., Castel, H., Bouchard, C., Monge-Roffarello, B., et al. (2012) · Diabetes · doi:10.2337/db11-0785 · Cited by 81
“See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details. diabetes.diabetesjournals.org DIABETES, VOL. 62, MARCH 2013 801 Moreover, the intracerebroventricular injection of ODN increases POMC mRNA levels and decreases NPY mRNA levels in the arcuate nucleus (25).”
BackgroundInfluentialModification of feeding circuits in the evolution of social behavior
Fischer, E. K., & O’Connell, L. A. (2017) · Journal of Experimental Biology · doi:10.1242/jeb.143859 · Cited by 74
“Peptide hormones important for feeding behavior Vertebrate peptide Invertebrate homolog Effect on feeding behavior Reference Agouti-related protein (AgRP) n/a Stimulant Rossi et al., 1998 α-Melanocyte stimulating hormone (α-MSH) n/a Suppressant Murphy et al., 1998 Brain-derived neurotrophic factor (BDNF) Neurotrophins…”
BackgroundWardlaw, S. L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7388 · Cited by 75
Perello, M., Stuart, R. C., & Nillni, E. A. (2006) · Endocrinology · doi:10.1210/en.2005-1533 · Cited by 74
Neurophysiology of hunger and satiety
Smith, P., & Ferguson, A. V. (2008) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.13 · Cited by 82
Neurochemical phenotype of hypothalamic neurons showing Fos expression 23 h after intracranial AgRP
Zheng, H., Corkern, M. M., Crousillac, S. M., Patterson, L. M., Phifer, C. B., & Berthoud, H. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00019.2002 · Cited by 74
“In contrast, intracerebroventricular injection of AgRP induces robust food intake (54) that lasts for several days (29).”
BackgroundForebrain melanocortin signaling enhances the hindbrain satiety response to CCK-8
Blevins, J. E., Morton, G. J., Williams, D. L., Caldwell, D. W., Bastian, L. S., Wisse, B. E., Schwartz, M. W., & Baskin, D. G. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90544.2008 · Cited by 73
“Blockade of central melanocortin signaling by intracerebroventricular administration of either the endogenous melanocortin receptor antagonist agouti-related peptide (AGRP) or the synthetic MC3/MC4 antagonist SHU9119 produces hyperphagia and obesity (19, 35, 38) and attenuates the anorexic response to leptin (14, 43).”
Regulation of Energy Balance in Birds by the Neuroendocrine Hypothalamus
Boswell, T. (2005) · The Journal of Poultry Science · doi:10.2141/jpsa.42.161 · Cited by 74
THE NEUROENDOCRINOLOGY OF OBESITY
Lustig, R. H. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70211-5 · Cited by 73
Apelin and the proopiomelanocortin system: a new regulatory pathway of hypothalamic α-MSH release
Goazigo, A. R.-L., Bodineau, L., Mota, N. D., Jeandel, L., Chartrel, N., Knauf, C., Raad, C., Valet, P., & Llorens‐Cortés, C. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00090.2011 · Cited by 78
Seal, L., Small, C. J., Dhillo, W. S., Stanley, S. A., Abbott, C. R., Ghatei, M. A., & Bloom, S. R. (2001) · Endocrinology · doi:10.1210/endo.142.10.8419 · Cited by 73
“Intracerebroventricular injection of MSH inhibits feeding (19), as does intranuclear injection of the long-acting MSH analog [Nle4,d-Phe7]MSH (NDP-MSH), whereas injection of AgRP-(83–132) increases feeding ( 20 ).”
BackgroundSelf-citationHaskell‐Luevano, C., Schaub, J. W., Andreasen, A., Haskell, K. R., Moore, M. C., Koerper, L. M., Rouzaud, F., Baker, H. V., Millard, W. J., Walter, G., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-109686 · Cited by 72
Constitutive Activity in Melanocortin-4 Receptor
Tao, Y. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-417197-8.00005-5 · Cited by 71
The Agouti-related protein and its role in energy homeostasis
Stütz, A. M., Morrison, C. D., & Argyropoulos, G. A. (2005) · Peptides · doi:10.1016/j.peptides.2004.12.024 · Cited by 75
Cai, X., Lister, C. A., Buckingham, R. E., Pickavance, L. C., Wilding, J. P. H., Arch, J. R. S., Wilson, S., & Williams, G. H. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00041-3 · Cited by 72
Nutrition and the circadian timing system
Stenvers, D. J., Jonkers‐Schuitema, C. F., Fliers, E., Bisschop, P. H. L. T., & Kalsbeek, A. (2012) · Progress in brain research · doi:10.1016/b978-0-444-59427-3.00020-4 · Cited by 70
Mode of leptin action in chicken hypothalamus
Dridi, S., Swennen, Q., Decuypere, E. M. P., & Buyse, J. G. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.034 · Cited by 71
KO's and organisation of peptidergic feeding behavior mechanisms
Beck, B. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00003-3 · Cited by 73
Dhillo, W. S., Small, C. J., Seal, L., Kim, M.-S., Stanley, S. A., Murphy, K. G., Ghatei, M. A., & Bloom, S. R. (2002) · Neuroendocrinology · doi:10.1159/000054712 · Cited by 71
“ICV administration of Agrp(83–132) produces a long-lasting increase in food intake and is able to reverse the anorectic action of α-MSH [”
BackgroundSelf-citationNeuropeptides in Hypothalamic Neuronal Disorders
Swaab, D. F. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)40003-5 · Cited by 69
Melanocortin-4 Receptor (MC4R) Agonists for the Treatment of Obesity
Nargund, R. P., Strack, A. M., & Fong, T. M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm058241a · Cited by 70
Kask, A., & Schiöth, H. B. (2000) · Brain Research · doi:10.1016/s0006-8993(00)03034-1 · Cited by 70
Li, J.-Y., Finniss, S., Yang, Y.-K., Zeng, Q., Qu, S.-Y., Barsh, G. S., Dickinson, C. J., & Gantz, I. (2000) · Endocrinology · doi:10.1210/endo.141.6.7462 · Cited by 74
Intraventricular melanin-concentrating hormone stimulates water intake independent of food intake
Clegg, D. J., Air, E. L., Benoit, S. C., Sakai, R. R., Seeley, R. J., & Woods, S. C. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00399.2002 · Cited by 69
Targeting Intermediary Metabolism in the Hypothalamus as a Mechanism to Regulate Appetite
Lopaschuk, G. D., Ussher, J. R., & Jaswal, J. S. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002428 · Cited by 71
Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity
Gan, H., Cerbone, M., & Dattani, M. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad033 · Cited by 75
Joppa, M. A., Gogas, K. R., Foster, A. C., & Markison, S. (2007) · Peptides · doi:10.1016/j.peptides.2006.11.021 · Cited by 69
An overview of mongenic and syndromic obesities in humans
Chung, W. K. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23372 · Cited by 76
“The autosomal dominant agouti promoter mutation A results in ubiquitous ectopic overexpression of agouti signaling protein (ASP) throughout the body, producing the characteristic yellow coat color when it antagonizes the binding of alpha melanocortin stimulating hormone (a MSH) at melancortin 1 receptors (MC1R) in the…”
BackgroundMurphy, B. A., Nunes, C. N., Ronan, J. J., Hanaway, M., Fairhurst, A., & Mellin, T. N. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.1.273 · Cited by 68
Prokineticin 2 Is a Hypothalamic Neuropeptide That Potently Inhibits Food Intake
Gardiner, J., Bataveljic, A., Patel, N. A., Bewick, G. A., Roy, D., Campbell, D., Greenwood, H. C., Murphy, K. G., Hameed, S., Jethwa, P. H., et al. (2009) · Diabetes · doi:10.2337/db09-1198 · Cited by 72
“The doses of -MSH and AgRP were chosen based on previous studies (35).”
Self-citationInhoff, T., Stengel, A., Peter, L., Goebel, M., Taché, Y., Bannert, N., Wiedenmann, B., Klapp, B. F., Mönnikes, H., & Kobelt, P. (2009) · Peptides · doi:10.1016/j.peptides.2009.11.024 · Cited by 69
Melanocortin activity in the amygdala controls appetite for dietary fat
Boghossian, S., Park, M., & York, D. A. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00591.2009 · Cited by 66
Effects of Neuropeptides and Leptin on Nutrient Partitioning: Dysregulations in Obesity
Jeanrenaud, B., & Rohner‐Jeanrenaud, F. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.339 · Cited by 66
Metadata
- Authors
- Rossi, M., Kim, M. S., Morgan, D. G. A., Small, C. J., Edwards, C. M. B., Sunter, D., Abusnana, S., Goldstone, A. P., Russell, S. H., Stanley, S. A., Smith, D. M., Yagaloff, K., Ghatei, M. A., & Bloom, S. R.
- Affiliations
- Hammersmith Hospital (GB)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1998-10
- Volume
- 139
- Issue
- 10
- Pages
- 4428-4431
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2171010063
- Cited by
- 576
- References
- 0
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 4 · 2023: 5 · 2022: 9 · 2021: 11 · 2020: 7 · 2019: 16 · 2018: 8 · 2017: 13 · 2016: 16 · 2015: 15 · 2014: 16 · 2013: 22 · 2012: 29
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- agouti-related protein, C-terminal fragment, alpha-melanocyte-stimulating hormone, melanocortin 3 receptor, melanocortin-4 receptor, dietary intake, hyperphagia, SHU9119, obesity, hypothalamus, cAMP signaling, intracerebroventricular administration
- MeSH terms
- alpha-MSH, Animals, Dose-Response Relationship, Drug, Eating, Injections, Intraventricular, Male, Peptide Fragments, Proteins, Rats, Wistar, Receptors, Corticotropin, Intercellular Signaling Peptides and Proteins, Receptor, Melanocortin, Type 3, Rats, Agouti Signaling Protein, Agouti-Related Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review